Cancer Specific Panels

Targeted drugs are entering to conventional oncology treatment every year. These drugs target specific mutant or abnormal proteins that drives cancer. Furthermore, these mutations and drugs can be grouped for disaese indications. This makes the process faster and more feasible.

Targeted drugs have proven to be a game-changer in the treatment of cancer. Unlike traditional chemotherapy, which kills both cancerous and healthy cells, targeted drugs are specifically designed to attack only the cancer cells. This not only increases the effectiveness of the treatment but also reduces the side effects.

Additionally, the use of targeted drugs has led to a better understanding of the genetic makeup of cancer. By identifying specific mutations or abnormal proteins that are driving the growth of cancer cells, doctors can prescribe drugs that specifically target these mutations. This personalized approach to treatment has led to better outcomes for patients, with higher response rates and longer survival times.

As more targeted drugs become available, the process of treating cancer is becoming faster and more feasible. By grouping mutations and drugs according to disease indications, doctors can quickly identify the appropriate treatment for each patient. This not only saves time but also minimizes the risk of side effects associated with traditional chemotherapy.

Overall, targeted drugs are a promising development in the fight against cancer. With ongoing research and development, it is hoped that these drugs will continue to improve outcomes for patients and eventually lead to a cure for this devastating disease.